The probiotic-mediated activation of Nrf-2 is shown to mediate significant antioxidant and anti-inflammatory effects, thus suppressing the onset of inflammation-induced CRC [248,274]. This evidence concerns the gene NFE2L2 and colorectal carcinoma.